Experiences with SARS-CoV-2 (Covid-19) in Trinidad and Tobago, a small island developing state: realities and opportunities.
COVID 19
Opportunities
Trinidad and Tobago
Journal
Lancet regional health. Americas
ISSN: 2667-193X
Titre abrégé: Lancet Reg Health Am
Pays: England
ID NLM: 9918232503006676
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
26
04
2023
revised:
27
07
2023
accepted:
28
08
2023
medline:
20
9
2023
pubmed:
20
9
2023
entrez:
20
9
2023
Statut:
epublish
Résumé
The COVID-19 pandemic has exerted significant global challenges that are expressed in a variety of socio-politico-economic scenarios, depending upon individual countries' preparedness and resilience. The impact COVID-19 in Small Island Developing States (SIDS), most of which are categorized as Lower and Middle-Income Countries, has been pronounced. Furthermore, many of these SIDS possess specific vulnerabilities to global threats. This paper contextualizes the experience of Trinidad and Tobago from some perspectives of geoeconomics, healthcare, and international relations. In many ways, the experience is similar to that of other SIDS with the inherent nuances of a post-colonial world. Trinidad and Tobago was ranked number one by the Oxford University COVID-19 Government Response Tracker (OxCGRT) "Lockdown rollback checklist: Do countries meet WHO recommendations for rolling back lockdown?". Despite the significant political support to combat the disease, by the end of 2022, the country had recorded over four thousand deaths and just over 50% of the population is vaccinated. This paper seeks to discuss the successes and challenges faced by this twin island state.
Identifiants
pubmed: 37727866
doi: 10.1016/j.lana.2023.100589
pii: S2667-193X(23)00163-1
pmc: PMC10505969
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100589Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
None of the authors listed have any financial benefits from the development and publication of this manuscript.
Références
Lancet Reg Health Am. 2023 Mar;19:100440
pubmed: 36743346
BMJ Glob Health. 2021 Aug;6(8):
pubmed: 34433544
J Nurs Manag. 2021 Nov;29(8):2329-2342
pubmed: 34182609
Int J Epidemiol. 2017 Aug 1;46(4):1312-1318
pubmed: 28938756
Respirology. 2021 Nov;26(11):1082-1084
pubmed: 34431158
Am J Trop Med Hyg. 2020 Aug;103(2):590-592
pubmed: 32524961
PLoS One. 2021 Dec 22;16(12):e0258348
pubmed: 34936646
J Glob Health. 2021 Nov 13;11:03121
pubmed: 34804512